Simple analytical tools for detection of impurities in biologics produced using the Sf-baculovirus platform

Cell & Gene Therapy Insights 2023; 9(4), 431

10.18609/cgti.2023.053

Published: 1 May 2023
FastFacts
Maya Yovcheva


Watch the video or view the poster to learn more about:

  • Regulatory guidance on residual DNA and Sf-rhabdovirus detection
  • Robust qPCR assays for residual DNA and Sf-rhabdovirus testing
  • Data demonstrating quantitation of residual Sf9 DNA and baculovirus DNA in purified biologic samples
  • Quantitation of Sf-rhabdovirus for a biologic sample during downstream processing